8-KRegulation FD

Walmart Inc. 8-K Report, Regulation FD Disclosure (Aug 22, 2023)

Filed August 22, 2023For Securities:WMT

Summary

Walmart Inc. has announced a significant development in resolving its opioid-related litigation. The company has accrued a liability of approximately $3.3 billion to settle substantially all opioid-related lawsuits and potential claims from states, political subdivisions, and tribes. This filing confirms that the State Settlement Framework has met the required participation threshold and will become effective on September 6, 2023. Investors should note that while the framework is now effective, Walmart will pay the remaining approximately $2.8 billion of the accrued liability in the third quarter of fiscal year 2024. Although the settlement is moving forward, eligible political subdivisions still have an extended period, until July 15, 2025, to join the State Settlement Framework. This resolution addresses a major legal overhang for the company.

Key Highlights

  • 1Walmart has agreed to a settlement framework to resolve substantially all opioid-related lawsuits and claims.
  • 2The total accrued liability for the settlement is approximately $3.3 billion.
  • 3The State Settlement Framework has met participation requirements and will become effective on September 6, 2023.
  • 4The remaining payment of approximately $2.8 billion is scheduled for Q3 FY2024.
  • 5Political subdivisions have until July 15, 2025, to join the State Settlement Framework.
  • 6This action aims to resolve a significant legal and financial contingency for the company.

Frequently Asked Questions